Autoimmune Hemolytic Anemia
📧 Sign up to get email alerts when something new happens for Autoimmune Hemolytic Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia [Phase 1]
Phase 1 study evaluating YTS109 Cells in relapsed/refractory autoimmune hemolytic anemia has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088 [Phase 1]
Phase 1 safety and tolerability study of SAR445088 in adults with cold agglutinin disease, previously treated vs untreated, has been termina…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia [Phase 1]
Phase 1 safety data on repurposing daratumumab for relapsed or refractory autoimmune antibody-mediated hemolytic anemia; the study has compl…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy. [Phase 1]
A Phase 1 clinical trial is evaluating CD19/BCMA CAR T-cells, including universal allogeneic CAR T-cells, in autoimmune hemolytic anemia pat…
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia [Phase 2]
Phase 2 trial assessing the safety and efficacy of ibrutinib in patients with refractory or relapsed autoimmune hemolytic anemia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA)
A clinical trial evaluating the role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia has completed, providing results on TFH inv…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia [Phase 2]
A phase 2 trial evaluating acalabrutinib for relapsed or refractory autoimmune hemolytic anemia in patients with chronic lymphocytic leukemi…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia [Phase 2]
Phase 2 clinical trial evaluating a single-dose anti-CD20 antibody in combination with bortezomib for relapsed or refractory autoimmune hemo…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia [Phase 2]
A Phase 2 clinical trial evaluating the safety and efficacy of zanubrutinib in refractory/relapsed autoimmune hemolytic anemia is ongoing, w…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia [Phase 2]
This clinical trial update reports Phase 2 results for INCB050465 in participants with autoimmune hemolytic anemia. Results were posted on 2…
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus [Phase 3]
Phase 3 clinical trial reappraising therapies for refractory autoimmune hemolytic anemia in systemic lupus erythematosus is in progress, wit…
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia [Phase 2]
Phase 2 clinical trial update for ibrutinib in steroid-refractory autoimmune hemolytic anemia.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Tacrolimus Treatment for Refractory Autoimmune Cytopenia [Phase 4]
A Phase 4 clinical trial update evaluating tacrolimus for refractory autoimmune cytopenia, including autoimmune hemolytic anemia and pure re…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating interleukin-2 in patients with active warm autoimmune hemolytic anemia resistant to conventional treatme…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Treatment of Autoimmune Thrombocytopenia (AITP) [Phase 1]
A Phase 1 clinical trial evaluating treatment for autoimmune thrombocytopenia has completed enrollment. The study also relates to autoimmune…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease [Phase 2]
Phase 2 trial update for bendamustine plus rituximab in Cold Agglutinin Disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT) [Phase 2]
Phase 2 trial evaluating rituximab-based combination chemotherapy in patients with chronic lymphocytic leukemia that did not respond to flud…
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia [Phase 3]
Phase 3 clinical trial evaluating prednisolone with or without the anti-CD20 antibody rituximab for autoimmune hemolytic anemia has complete…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. [Phase 2]
Phase 2 trial evaluating the efficacy and safety of combining levamisole with prednisolone for warm autoimmune hemolytic anemia; current sta…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia [Phase 2]
Phase 2 single-arm pilot study evaluating low-dose rituximab plus standard prednisone for idiopathic autoimmune hemolytic anemia; the trial …
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias [Phase 2, Phase 3]
This clinical trial investigates combining alemtuzumab and rituximab to treat refractory autoimmune cytopenias, including idiopathic thrombo…
-
CLINICAL_TRIALS trial_result · 2008-09-10Clinical Trial Update: Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease [Phase 2]
A Phase II trial evaluated high-dose cyclophosphamide in patients with severe autoimmune hematologic disease. The study focused on autoimmun…